Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndrome
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000045226
- Lead Sponsor
- Akishima Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
eGFR<45 mL/min/1.73 m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c, BMI, and apnea-hypopnea index
- Secondary Outcome Measures
Name Time Method Serum lipid profile, serum parameters of hepatic function, and serum uric acid level